February 05, 2020
According to a recent study titled ‘Continuous Renal Replacement Therapy Market Size By Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Slow Continuous Ultrafiltration), By Product (Instruments, Consumables), By Therapy (Renal, Non-renal) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report LLC, the global continuous renal replacement therapy market is projected to cross USD 1.4 billion by the year 2025.
Rising prevalence of diabetes coupled with the growing geriatric population is fueling the growth of continuous renal replacement therapy market. Diabetes is the leading factor for renal disorders. Moreover, type 2 diabetes patients have a higher risk of renal disorders. Likewise, geriatric population is more susceptible to kidney disorders and renal failures, thereby augmenting the market outlook. On the other hand, the complications and side effects associated with continuous renal replacement therapy may hamper the market growth in the coming years.
In terms of modality, continuous renal replacement therapy from the continuous venovenous hemodialysis segment was worth USD 410 million in the year 2018 and is expected to witness a significant growth during the forecast period. High efficiency, technical advantages, and substantial solute clearance are the factors responsible for the rising preference towards continuous venovenous hemodialysis.
Based on the product type, consumables segment is expected to grow with a CAGR of 7.0% during the forecast period. To ensure patient safety, consumables such as fistula needles needs to be replaced after every step during the continuous renal replacement therapy (CRRT) treatment to prevent contamination, thereby, propelling the demand for consumables.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1357095/
Speaking of the therapy type, non-renal therapy segment accounted for USD 180 million in 2018 and is anticipated to grow significantly during the predicted timeline. CRRT therapies can treat sepsis, inflammatory syndromes, and other non-renal disorders. This factor coupled with the application of CRRT therapies in removal of mediators from blood circulation is boosting the segmental growth.
Considering the geographical landscape, Europe continuous renal replacement therapy market is projected to grow with a CAGR of 6% over the analysis period. Rising number of chronic disease cases among the baby boomer generation in tandem with rising diabetes incidences are fostering the regional growth.
Key players of continuous renal replacement therapy market are Fresenius Medical Care, B.Braun Melsungen, Medical Components, Asahi Kasei Corporation, Nxtstage, Infomed, Medica, Medites, NikkisoToray, Baxter International, and Medtronic.
Frequently Asked Questions (FAQ) :